Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
- Revenue in -- (TTM)--
- Net income in --
- Incorporated1919
- Employees--
- LocationOlympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
- Phone+81 333402111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp/
Holder | Shares | % Held |
---|---|---|
Swiss Life Asset Management AGas of 31 Dec 2021 | 83.76k | 0.01% |
Capital Research & Management Co. (World Investors)as of 30 Nov 2020 | 61.73k | 0.01% |
Envestnet Asset Management, Inc.as of 28 Feb 2022 | 59.19k | 0.01% |
Yousif Capital Management LLCas of 31 Mar 2022 | 20.13k | 0.00% |
Lazard Asset Management LLCas of 31 May 2022 | 18.64k | 0.00% |
CapFinancial Partners LLCas of 31 Mar 2022 | 10.03k | 0.00% |
Private Capital Group LLCas of 31 Mar 2022 | 2.64k | 0.00% |
PNC Investments LLCas of 31 Mar 2022 | 2.45k | 0.00% |
Nikko Asset Management Asia Ltd.as of 31 Dec 2021 | 400.00 | 0.00% |
Sierra Capital LLCas of 31 Mar 2022 | 143.00 | 0.00% |